These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 29090451)

  • 21. Therapeutic approaches for lysosomal storage diseases: a patent update.
    Urbanelli L; Sagini K; Polidoro M; Brozzi A; Magini A; Emiliani C
    Recent Pat CNS Drug Discov; 2013 Aug; 8(2):91-109. PubMed ID: 23713988
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Non-neuronopathic lysosomal storage disorders: Disease spectrum and treatments.
    Pastores GM; Hughes DA
    Best Pract Res Clin Endocrinol Metab; 2015 Mar; 29(2):173-82. PubMed ID: 25987171
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gene therapy for lysosomal storage disorders: recent advances for metachromatic leukodystrophy and mucopolysaccaridosis I.
    Penati R; Fumagalli F; Calbi V; Bernardo ME; Aiuti A
    J Inherit Metab Dis; 2017 Jul; 40(4):543-554. PubMed ID: 28560469
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current and potential therapeutic strategies for mucopolysaccharidoses.
    Noh H; Lee JI
    J Clin Pharm Ther; 2014 Jun; 39(3):215-24. PubMed ID: 24612142
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapeutic Approaches in Lysosomal Storage Diseases.
    Fernández-Pereira C; San Millán-Tejado B; Gallardo-Gómez M; Pérez-Márquez T; Alves-Villar M; Melcón-Crespo C; Fernández-Martín J; Ortolano S
    Biomolecules; 2021 Nov; 11(12):. PubMed ID: 34944420
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of brain disease in the mucopolysaccharidoses.
    Scarpa M; Orchard PJ; Schulz A; Dickson PI; Haskins ME; Escolar ML; Giugliani R
    Mol Genet Metab; 2017 Dec; 122S():25-34. PubMed ID: 29153844
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enzyme Replacement Therapy: A Review and Its Role in Treating Lysosomal Storage Diseases.
    Li M
    Pediatr Ann; 2018 May; 47(5):e191-e197. PubMed ID: 29750286
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel treatment for neuronopathic lysosomal storage diseases--cell therapy/gene therapy.
    Eto Y; Ohashi T
    Curr Mol Med; 2002 Feb; 2(1):83-9. PubMed ID: 11898850
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Current therapeutic strategies in lysosomal disorders].
    Kaminsky P; Lidove O
    Presse Med; 2014 Nov; 43(11):1174-84. PubMed ID: 24863660
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gene Therapy for Lysosomal Storage Disorders: Ongoing Studies and Clinical Development.
    Massaro G; Geard AF; Liu W; Coombe-Tennant O; Waddington SN; Baruteau J; Gissen P; Rahim AA
    Biomolecules; 2021 Apr; 11(4):. PubMed ID: 33924076
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Highlights on Genomics Applications for Lysosomal Storage Diseases.
    La Cognata V; Guarnaccia M; Polizzi A; Ruggieri M; Cavallaro S
    Cells; 2020 Aug; 9(8):. PubMed ID: 32824006
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gene therapy for lysosomal storage diseases and peroxisomal diseases.
    Ohashi T
    J Hum Genet; 2019 Feb; 64(2):139-143. PubMed ID: 30498239
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lysosomal storage diseases: current therapies and future alternatives.
    Leal AF; Espejo-Mojica AJ; Sánchez OF; Ramírez CM; Reyes LH; Cruz JC; Alméciga-Díaz CJ
    J Mol Med (Berl); 2020 Jul; 98(7):931-946. PubMed ID: 32529345
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Advances in therapies for neurological lysosomal storage disorders.
    Ellison S; Parker H; Bigger B
    J Inherit Metab Dis; 2023 Sep; 46(5):874-905. PubMed ID: 37078180
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New biotechnological and nanomedicine strategies for treatment of lysosomal storage disorders.
    Muro S
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2010; 2(2):189-204. PubMed ID: 20112244
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The basics of lysosomal storage diseases].
    Tamò R; Rohrbach M; Baumgartner M; Beuschlein F; Nowak A
    Ther Umsch; 2018 Nov; 75(4):199-207. PubMed ID: 30468118
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment for Lysosomal Storage Disorders.
    Sheth J; Nair A
    Curr Pharm Des; 2020; 26(40):5110-5118. PubMed ID: 33059565
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cell and gene-based therapies for the lysosomal storage diseases.
    Hodges BL; Cheng SH
    Curr Gene Ther; 2006 Apr; 6(2):227-41. PubMed ID: 16611044
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuronopathic lysosomal storage disorders: Approaches to treat the central nervous system.
    Scarpa M; Bellettato CM; Lampe C; Begley DJ
    Best Pract Res Clin Endocrinol Metab; 2015 Mar; 29(2):159-71. PubMed ID: 25987170
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ERT Degrades Gene Therapy for Storage Disorder.
    Markusic DM
    Mol Ther; 2019 Jul; 27(7):1207-1208. PubMed ID: 31202634
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.